Role of Bile Acid Pathway Intermediates in Pathology of CTX (2023)
Attributed to:
Mass Spectrometry Based Lipidomics and Metabolomics to Drive Bioscience Discovery
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5281/zenodo.10050200
Publication URI: https://zenodo.org/doi/10.5281/zenodo.10050200
Type: Preprint